Data Integrity Risk Assessment
Conducting data integrity risk assessments for GxP systems to identify and mitigate documentation risks.
Good Pharmaceutical PracticeDocument Numbering and Version Control
Systems for document numbering and version control in pharmaceutical GxP environments to ensure traceability.
Good Pharmaceutical PracticeElectronic Records and 21 CFR Part 11
Understanding 21 CFR Part 11 requirements for electronic records and signatures in FDA-regulated pharmaceutical environments.
Good Pharmaceutical PracticeEU Annex 11 Compliance
Requirements for EU Annex 11 compliance covering computerized systems in the pharmaceutical manufacturing environment.
Good Pharmaceutical PracticeHybrid Systems (Paper and Electronic)
Managing hybrid systems that combine paper and electronic records in pharmaceutical GxP environments.
Good Pharmaceutical PracticeIntroduction to Good Documentation Practices (GDP)
An introduction to Good Documentation Practices (GDP) and their role in maintaining data integrity in regulated environments.
Good Pharmaceutical PracticeLaboratory Notebook Practices
Proper laboratory notebook practices for maintaining data integrity in pharmaceutical R&D and QC environments.
Good Pharmaceutical PracticeTraining for Good Documentation Practices
Training programs for Good Documentation Practices to ensure personnel competence in GxP documentation.
Good Pharmaceutical PracticeApparatus, Materials, and Reagents
GLP requirements for apparatus, materials, and reagents used in non-clinical safety studies.
Good Pharmaceutical Practice